Clinical Trials List
2025-02-01 - 2032-12-31
Phase III
Recruiting6
ICD-10C50.911
Malignant neoplasm of unspecified site of right female breast
ICD-10C50.912
Malignant neoplasm of unspecified site of left female breast
ICD-10C50.919
Malignant neoplasm of unspecified site of unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.9
Malignant neoplasm of female breast, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Kuo-Ting Lee
- Jui-Hung Tsai 無
- Shang-Hung Chen 無
- 魏慈慧 無
- Chun-Hui Lee
- 楊舜如 無
- 黃怡菁 無
- Zhu-Jun Loh 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 邱仁輝
- 馮晉榮
- Yi-Fang Tsai 無
- 郭懿萱
- Chi-Cheng Huang 無
- 鄭涵方 無
- 林燕淑 無
- 陳柏方 無
- Chun-Yu Liu
- Jiun-I Lai 無
- 陳彥蓁
- Ta-Chung Chao
- 賴亦貞 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
450 participants
